搜索:
            
 
     Beijing Four Rings Biopharmaceutical.Co., Ltd.
Beijing Four Rings Biopharmaceutical.Co., Ltd.
2010-05-16 22:08:33 来源:我的网站 浏览:16386次    

  

 

 

Beijing Four Rings Biopharmaceutical Co., Ltd., former military enterprise (Sihuan Bioengineering Plant) subordinated to  Institute of Biotechnology of the Academy of Military Medical Sciences, is a new high-tech enterprise integrating science, industry and trade as a whole. Founded in 1988, it has committed itself to the research, development, production and sales of bio-engineering technical products as one of the first group of gene engineering products manufacturers of MOH. In 2001, Sihuan Bioengineering Plant was purchased by Jiangsu Sihuan Bioengineering Co.,Ltd. and changed name to Beijing Four Rings Biopharmaceutical Co., Ltd. After restructuring and feeding into capital, especially introducing the group's successful management and operation mode, the enterprise will step into high-speed development. In 2004, the company built a new factory in Beijing Economic & Technology Development Zone with an investment of 150 million RMB. The new factory site took a space of 17,000 square meters, designed by CSV Company Italia according to EU GMP standard. In December 2005, the new factory passed the GMP authentication of State Drug Administration of China. In October 2007, EPO and G-CSF workshops passed the Colombia GMP Inspection ( WHO standard). In 2007, we started cooperation with Kambrige Life Sciences Australia on the project of Oral Il-2 tablet. Advanced equipments, stable product quality and complete quality control system guarantee a high quality brand of FOUR RINGS.

 

 
    地址:北京市亦庄经济开发区建安街5号 邮编:100176
电话:0086-10 51570800, 51570870, 51570818, 51570855
传真:0086-10 51410080, 51570860
网址:www.bjshsw.com www.bjshsw.com.cn
您当前位置:网站首页 >> english >> 阅读文章

上一篇:没有了
下一篇:Contact Us

相关文章

2010-04-13 14:59:52
2010-04-13 14:59:29
2010-04-13 14:59:07
2010-04-13 14:58:49
2010-04-13 14:58:33
2010-04-13 14:58:08
2010-04-13 14:57:38
2010-04-13 14:57:23

文章评论

现在有0人对本文发表评论 查看所有评论